药物之间的相互作用1329045个记录(本栏目收费,不能展示细节,电话13136136841)
药物之间的相互作用
Tenocyclidine
Tocilizumab
The risk or severity of adverse effects can be increased when Tocilizumab is combined with Ozanimod.
Tenocyclidine
Canakinumab
The risk or severity of adverse effects can be increased when Canakinumab is combined with Ozanimod.
Tenocyclidine
Human interferon omega-1
The risk or severity of adverse effects can be increased when Human interferon omega-1 is combined with Ozanimod.
Tenocyclidine
Briakinumab
The risk or severity of adverse effects can be increased when Briakinumab is combined with Ozanimod.
Tenocyclidine
Glatiramer
The risk or severity of adverse effects can be increased when Glatiramer is combined with Ozanimod.
Tenocyclidine
Interferon alfa
The risk or severity of adverse effects can be increased when Interferon alfa is combined with Ozanimod.
Tenocyclidine
Trabectedin
The risk or severity of adverse effects can be increased when Trabectedin is combined with Ozanimod.
Tenocyclidine
Afelimomab
The risk or severity of adverse effects can be increased when Afelimomab is combined with Ozanimod.
Tenocyclidine
Pirfenidone
The risk or severity of adverse effects can be increased when Pirfenidone is combined with Ozanimod.
Tenocyclidine
Thiotepa
The risk or severity of adverse effects can be increased when Thiotepa is combined with Ozanimod.
Tenocyclidine
Brequinar
The risk or severity of adverse effects can be increased when Brequinar is combined with Ozanimod.
Tenocyclidine
2-Methoxyethanol
The risk or severity of adverse effects can be increased when 2-Methoxyethanol is combined with Ozanimod.
Tenocyclidine
Vorinostat
The risk or severity of adverse effects can be increased when Vorinostat is combined with Ozanimod.
Tenocyclidine
Castanospermine
The risk or severity of adverse effects can be increased when Castanospermine is combined with Ozanimod.
Tenocyclidine
Denosumab
The risk or severity of adverse effects can be increased when Denosumab is combined with Ozanimod.
Benzethidine
Cyclopenthiazide
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cyclopenthiazide.
Benzethidine
Mebutizide
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Mebutizide.
Benzethidine
Omega-3-acid ethyl esters
The risk or severity of bleeding can be increased when Omega-3-acid ethyl esters is combined with Nafamostat.
Benzethidine
Cefamandole nafate
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Cefamandole nafate.
Benzethidine
Ceftezole
The therapeutic efficacy of Nafamostat can be decreased when used in combination with Ceftezole.